patent.fyi
Applications  /  US 2026/0356819
United States Patent Application Publication

US 2026/0356819 A1

Published
Nov 12, 2026
Filed
Jun 3, 2024
Earliest date on the face
Jun 1, 2023
Classification
C07D 403/04
First published here
Nov 20, 2026

Generated automatically. Not reviewed by a person. Not legal advice or an opinion.

Section 1 · machine-generated

What if?

Questions about how individual parts of claim 1 might be changed. A question may describe something different from what the claim language recites, or a version of it; no view is offered on which.

1.1Ring oxygen at A

What ifWhat if A were an oxygen atom bonded to the two neighboring ring atoms?
Claim language“CO, CH2, or CD2”

The divalent oxygen closes the five-membered fused ring and bonds directly to the ring nitrogen. The carbonyl elsewhere in the ring retains its position, giving a cyclic carbamate.

1.2Methylthio at the Ra1 position

What ifWhat if the Ra1 position carried methylthio as its substituent?
Claim language“C1-6 alkoxy, deuterated C1-6 alkoxy”

Ra1 attaches through sulfur as –S–CH3. Sulfur joins the scaffold to a single terminal methyl group and gives the substituent a longer bond to the scaffold than oxygen provides in a methoxy group.

1.3Carboxamide on the isoindoline ring

What ifWhat if one aromatic carbon of the isoindoline ring carried a primary carboxamide?
Claim language“nitro, amino, cyano”

The aromatic carbon bonds directly to the carbonyl carbon of –C(O)NH2. The carbonyl oxygen accepts hydrogen bonds and the amide NH groups donate hydrogen bonds.

1.5Saturated ethylene as R

What ifWhat if a saturated ethylene group connected the isoindoline ring to L at R?
Claim language“alkenylene, alkynylene”

The –CH2–CH2– segment joins the isoindoline ring to L through two tetrahedral carbons. Rotation about the central carbon–carbon bond gives the segment multiple conformations.

1.7Trans cyclohexane as A1

What ifWhat if trans-cyclohexane-1,4-diyl served as the sole A1 ring?
Claim language“nitrogen-containing heterocyclylene, arylene, or heteroarylene”

The cyclohexane connects the flanking groups at carbons 1 and 4 on opposite faces of the ring. Its diequatorial chair places both attachment bonds in equatorial positions.

Section 2 · machine-generated

Variations

Further arrangements of the same subject matter, described here as of the publication date at the foot of this page.

Other field of use

Reference samples for analytical training

A training kit uses an oxoisoindolinyl-substituted tetrahydropyrimidinedione and its corresponding deuterated analogue as reference compounds. The kit contains separate coded vials of each compound and a mixed reference vial. Liquid chromatography separates the components from sample impurities, and mass spectrometry distinguishes the two reference compounds by their molecular ion masses.

Component substitution

Acyclic phosphine oxide terminal group

A dimethylphosphine oxide group replaces the terminal amide of a representative derivative. The linker bonds directly to phosphorus through a carbon–phosphorus bond, forming a terminal –P(=O)(CH₃)₂ group. The phosphoryl oxygen provides a hydrogen-bond acceptor at the distal end of the linker.

Sulfoximine connector with defined stereochemistry

An N-methylsulfoximine replaces the sulfone connector between the isoindoline ring and the carbon end of the linker. Sulfur bonds to both fragments and carries an oxo group and an N-methyl imino group. The two sulfur stereoisomers share the same connectivity and present different orientations of the oxo and imino groups relative to the core.

Parameter or scale variation

Extended polyethylene glycol linker series

Three derivatives retain the same oxoisoindolinyl-substituted tetrahydropyrimidinedione core and terminal phenoxy group. Their linkers contain 12, 16, or 24 oxyethylene repeat units, with the same attachment chemistry at both ends. Each repeat adds two backbone carbons and one ether oxygen, increasing the maximum end-to-end length and the number of rotatable bonds.

Combination with existing systems

Immobilized ligand for affinity chromatography

A derivative bearing a terminal primary amine couples to activated carboxyl groups on porous agarose beads through an amide bond. The linker projects the oxoisoindolinyl-substituted tetrahydropyrimidinedione core into the aqueous phase inside the packed bed. A buffered sample passes through the bed, and a soluble cereblon-binding ligand competes for the retained protein during elution.

Automated or data-driven variant

Software ranking of linker conformations

Software attaches candidate linkers at the same core and terminal-group attachment points in molecular graphs. A distance-geometry algorithm generates 100 conformers per candidate, and a molecular mechanics force field minimizes each conformer. The software ranks candidates by the fraction of minimized conformers whose attachment-point separations fall within a specified distance interval.

Specific version of a part

Two substituents on neighboring carbons

The substitution count m is 2. Fluorine and methyl occupy neighboring aromatic carbons of the isoindoline ring, with each substituent attached directly to its ring carbon.

Nitr​ogen with an ethyl substituent

Ra6 is ethyl, so R is –N(CH2CH3)–. The nitrogen joins an aromatic carbon of the isoindoline ring to a terminal methylene of L and forms a tertiary amine.

Fluorine on a phenylene ring

A1 is benzene-1,4-diyl, a1 is 1, and Ry1 is fluorine at carbon 2. The flanking groups attach at carbons 1 and 4.

Single trans cyclobutane ring

A2 is trans-cyclobutane-1,3-diyl, y2 is 1, and a2 is 0. The two attachment bonds lie on opposite faces of the four-membered ring at carbons 1 and 3.

Section 3 · quoted from USPTO records

Other work

Passages reproduced word for word from two earlier-published U.S. patent documents, placed beside the language of claim 1. No characterization is offered. Each passage is marked A or B for the document it comes from; ¶ numbers are the paragraph numbers in the USPTO’s published full text of that document.

Document AUS 2014/0206649 A1
Published
Jul 24, 2014
Filed
Feb 24, 2012
Class
A61K 31/675
Document BUS 2015/0005303 A1
Published
Jan 1, 2015
Filed
Sep 18, 2014
Class
C07D 401/04
Claim 1
Document A
Document B
1.1A represents CO, CH2, or CD2
A mixture of 5-aminomethyl-2-[(3S)-3-methyl-2,6-dioxo-piperidin-3-yl)-isoindole-1,3-dione hydrochloride (0.85 g, 2.5 mmol), 2-thiophenecarbonyl chloride (0.37 g, 2.5 mmol) and triethylamine (0.51 g, 5.0 mmol) in anhydrous acetonitrile (20 mL) was stirred at room temperature for 1 hour.
B · US 2015/0005303 A1 · ¶ 286
1.2Ra1, Ra2, Ra3, and Ra4 each independently represent hydrogen, deuterium, halogen, C1-6 alkyl, halogenated C1-6 alkyl, deuterated C1-6 alkyl, C1-6 alkoxy, deuterated C1-6 alkoxy, or halogenated C1-6 alkoxy
A composition comprising a compound selected from compounds of Formula Ia and pharmaceutically acceptable salts, solvates, hydrates, and N-oxides thereof: wherein: R1, R2, R3, R4, R5, and R6 are each independently selected from: H and C1-C6 alkyl;
A · US 2014/0206649 A1 · claim 1
1.3(Ra5)m indicates that the isoindoline ring to which it is attached is optionally substituted with m Ras, with each Ras being the same or different and each independently representing deuterium, halogen, hydroxy, mercapto, nitro, amino, cyano, C1-6 alkyl, halogenated C1-6 alkyl, deuterated C1-6 alkyl, C1-6 alkoxy, deuterated C1-6 alkoxy, halogenated C1-6 alkoxy, C2-6 alkenyl or C2-6 alkynyl
1.4m represents an integer of 0, 1, 2, or 3
1.5R represents O, S, S(O), S(O)2, alkenylene, alkynylene, or N(Ra6)
1.6wherein Ra6 represents H or C1-3 alkyl, or R represents a bond
1.7or R represents: wherein each ring A1 is the same or different and independently represents nitrogen-containing heterocyclylene, arylene, or heteroarylene, y1 represents an integer of 1 or 2, and (Ry1)a1 indicates that each ring A1 is independently optionally substituted with a1 Ry1 substituents
In some embodiments, R14 is selected from: methylene, ethylene, cyclopropylene, cyclobutylene, piperidinylene, pyridinylene, tetrahydropyranylene, thiazolylene, cyclohexylene, cyclopentylene, cyclopentenylene, dioxohexahydrothiopyranylene, pyrrolidinylene, tetrahydrothiophenylene, propylene, 3,3-oxetanylene, and —SO2—; wherein said ethylene, methylene, piperidinylene, propylene, and pyrrolidinylene are each optionally substituted with one or more substituents selected from: m
A · US 2014/0206649 A1 · ¶ 326
1.8wherein each Ry1 independently represents deuterium, C1-6 alkyl, deuterated C1-6 alkyl, halogenated C1-6 alkyl, C1-6 alkoxy, halogenated C1-6 alkoxy, halogen, amino, hydroxy, mercapto, cyano, C2-6 alkynyl or C2-6 alkenyl, and a1 represents an integer of 0-20
(C0-C10)alkyl-(5 to 10 membered heteroaryl or heterocycle), said heteroaryl or heterocycle optionally substituted with one or more of (C1-C6)alkyl, halogen, oxo, (C1-C6)alkoxy, or —Z—(C1-C6)alkyl, wherein Z is S or SO2, and wherein said (C1-C6)alkyl may be optionally substituted with one or more halogen;
B · US 2015/0005303 A1 · ¶
1.9each ring A2 is the same or different and independently represents heterocyclylene, cycloalkylene, arylene, or heteroarylene, y2 represents an integer of 0 or 1, and (Ry2)a2 indicates that each ring A2 is independently optionally substituted with a2 Ry2 substituents
R8 is —R14—R15—R16—R17; wherein: R14 is selected from: C1-C6 alkylene, C3-C7 cycloalkenylene, C3-C7 cycloalkylene, heteroarylene, and heterocyclylene; wherein said C1-C6 alkylene and heterocyclylene are each optionally substituted with one or more substituents selected from: C1-C6 alkoxycarbonyl, C1-C6 alkyl, C3-C7 cycloalkyl, aryl, carboxy, heteroaryl, heterocyclyl, and hydroxyl; wherein said C1-C6 alkyl and aryl are optionally substituted with one substituent selected from:
A · US 2014/0206649 A1 · ¶ 8
1.10wherein each Ry2 independently represents deuterium, C1-6 alkyl, deuterated C1-6 alkyl, halogenated C1-6 alkyl, C1-6 alkoxy, halogenated C1-6 alkoxy, halogen, amino, hydroxy, mercapto, cyano, C2-6 alkynyl or C2-6 alkenyl, and a2 represents an integer of 0-20
1.11L represents: wherein Rw1 is linked to R, and Rw2 is linked to X
1.12Rw2 represents a bond, C(O), C(O)NH, NHC(O), or N(Ra6) wherein Ra6 represents H or C1-3 alkyl each ring A3 is the same or different and independently represents heterocyclylene, cycloalkylene, arylene, or heteroarylene, y3 represents an integer of 0, 1, 2, or 3, and (Ry3)a3 indicates that each ring A3 is independently optionally substituted with a3 Ry3 substituents wherein each Ry3 independently represents deuterium, C1-6 alkyl, deuterated C1-6 alkyl, halogenated C1-6 alkyl, C1-6 alkoxy, halogenated C1-6 alkoxy, halogen, amino, hydroxy, mercapto, cyano, C2-6 alkynyl or C2-6 alkenyl, and a3 represents an integer of 0-20 each ring A4 is the same or different and independently represents heterocyclylene, cycloalkylene, arylene, or heteroarylene, y4 represents an integer of 0, 1, 2, or 3, and (Ry4)a4 indicates that each ring A4 is independently optionally substituted with a4 Ry4 substituents wherein each Ry4 independently represents deuterium, C1-6 alkyl, deuterated C1-6 alkyl, halogenated C1-6 alkyl, C1-6 alkoxy, halogenated C1-6 alkoxy, halogen, amino, hydroxy, mercapto, cyano, C2-6 alkynyl or C2-6 alkenyl, and a4 represents an integer of 0-20 each ring A5 is the same or different and independently represents heterocyclylene, cycloalkylene, arylene, or heteroarylene, y5 represents an integer of 0, 1, 2, or 3, and (Ry5) as indicates that each ring A5 is independently optionally substituted with a5 Ry5 substituents wherein each Ry5 independently represents deuterium, C1-6 alkyl, deuterated C1-6 alkyl, halogenated C1-6 alkyl, C1-6 alkoxy, halogenated C1-6 alkoxy, halogen, amino, hydroxy, mercapto, cyano, C2-6 alkynyl or C2-6 alkenyl, and a5 represents an integer of 0-20 Rw1 represents a bond or optionally substituted linear or branched C1-20 alkylene wherein any one or more methylene groups in the main carbon chain skeleton of the linear or branched C1-20 alkylene are optionally replaced by one or more groups selected from Ra, Rb, and any combination thereof wherein each Ra is independently selected from the group consisting of: O, C(O), OC(O), S, S(O), S(O)2, S(O)2N(Ra7), N(Ra7)S(O)2, C(O)N(Ra7), N(Ra7)C(O), N(Ra7), and N(Ra7)C(O)N(Ra7), where each Ra7 independently represents H or C1-6 alkyl, and when any two or more methylene in the main carbon chain skeleton of the linear or branched C1-20 alkylene are replaced by two or more Ra groups, the Ra groups are not directly connected to each other wherein each Rb is independently selected from the group consisting of: optionally substituted cycloalkylene, optionally substituted arylene, optionally substituted heterocyclylene, optionally substituted heteroarylene, alkynylene, alkenylene, and any combination thereof X represents: NR1R2, C(O)NR3R4, NHC(O)R5, NHC(O)NR6R7, OR8, SR9, S(O)2NR10R11, or N(R12)S(O)2R13 wherein R1, R3, R4, R5, R6, R7, R9, R10, R11, and R12 each independently represent H, optionally substituted linear or branched alkyl, optionally substituted cycloalkyl, optionally substituted aryl, optionally substituted heterocyclyl, or optionally substituted heteroaryl, and wherein R2, R8, and R13 each independently represent optionally substituted linear or branched alkyl, optionally substituted cycloalkyl, optionally substituted aryl, optionally substituted heterocyclyl, or optionally substituted heteroaryl, or wherein R3 and R4, together with the nitrogen atom to which they are attached, form an optionally substituted 4- to 30-membered nitrogen-containing heterocyclyl or wherein ring A represents heterocyclylene, cycloalkylene, arylene, or heteroarylene, and (Rd1)n1 indicates that ring A is optionally substituted with n1 Rd1 substituents wherein each Rdi independently represents deuterium, C1-6 alkyl, deuterated C1-6 alkyl, halogenated C1-6 alkyl, C1-6 alkoxy, halogenated C1-6 alkoxy, halogen, amino, hydroxy, mercapto, cyano, oxo, C2-6 alkynyl or C2-6 alkenyl, and n1 represents an integer of 0-20 Rc represents NRc1, C(O), CRc2Rc3, or a bond wherein Rc1 represents H, optionally substituted linear or branched alkyl, optionally substituted cycloalkyl, optionally substituted aryl, optionally substituted heterocyclyl, or optionally substituted heteroaryl wherein Rc2 and Rc3 each independently represent H, halogen, optionally substituted linear or branched alkyl, optionally substituted cycloalkyl, optionally substituted aryl, optionally substituted heterocyclyl, or optionally substituted heteroaryl each ring B is the same or different and independently represents heterocyclylene, cycloalkylene, arylene, or heteroarylene, m1 represents an integer of 0, 1, 2, or 3, and (Ra2)n2 indicates that each ring B is independently optionally substituted with n2 Ra2 substituents wherein each Ra2 independently represents deuterium, C1-6 alkyl, deuterated C1-6 alkyl, halogenated C1-6 alkyl, C1-6 alkoxy, halogenated C1-6 alkoxy, halogen, amino, hydroxy, mercapto, cyano, oxo, C2-6 alkynyl or C2-6 alkenyl, and n2 represents an integer of 0-20 Re represents S, O, CRe1Re2, or a bond wherein Re1 and Re2 each independently represent H, halogen, optionally substituted linear or branched alkyl, optionally substituted cycloalkyl, optionally substituted aryl, optionally substituted heterocyclyl, or optionally substituted heteroaryl each ring C is the same or different and independently represents heterocyclyl, cycloalkyl, aryl, or heteroaryl, m2 represents an integer of 0, 1, 2, or 3, and (Ra3)n3 indicates that each ring C is independently optionally substituted with n3 Rd3 substituents wherein each Ra3 independently represents deuterium, C1-6 alkyl, deuterated C1-6 alkyl, halogenated C1-6 alkyl, C1-6 alkoxy, halogenated C1-6 alkoxy, halogen, amino, hydroxy, mercapto, cyano, oxo, C2-6 alkynyl or C2-6 alkenyl, and n3 represents an integer of 0-20 or wherein —X1-X2— represents —(CH2)1-6—, —(CH2)1-5O—, —CH2O(CH2)1-4—, —(CH2)1-4OCH2—, —(CH2)1-5NH—, —CH2NH(CH2)1-4—, or —(CH2)1-4NHCH2— p1, p2, and p3 each independently represent an integer of 1, 2, 3, or 4 the ring containing —X1-X2— is optionally substituted with one or more substituents selected from the group consisting of deuterium, C1-6 alkyl, deuterated C1-6 alkyl, halogenated C1-6 alkyl, C1-6 alkoxy, halogenated C1-6 alkoxy, halogen, amino, hydroxy, mercapto, cyano, oxo, C2-6 alkynyl or C2-6 alkenyl, or any combination thereof or wherein —X3-X4— represents —(CH2)1-6—, —(CH2)1-5O—, —CH2O(CH2)1-4—, —(CH2)1-4OCH2—, —(CH2)1-5NH—, —CH2NH(CH2)1-4—, or —(CH2)1-4NHCH2— p4 and p5 each independently represent an integer of 1, 2, 3, or 4 the benzo-fused ring containing —X3-X4— is optionally substituted with one or more substituents selected from the group consisting of deuterium, C1-6 alkyl, deuterated C1-6 alkyl, halogenated C1-6 alkyl, C1-6 alkoxy, halogenated C1-6 alkoxy, halogen, amino, hydroxy, mercapto, cyano, oxo, C2-6 alkynyl, C2-6 alkenyl, or any combination thereof.
R15 is selected from: —C(O)NH—, —C(O)—, —C(O)O—, C1-C6 alkylene, C3-C7 cycloalkylene, heteroarylene, and heterocyclylene; wherein said heterocyclylene is optionally substituted with C1-C6 alkyl; or R15 is absent;
A · US 2014/0206649 A1 · ¶ 8

An empty cell means only that no passage was reproduced there.

Statements in these documents
Also provided is a composition comprising a compound of Formula Ia or a pharmaceutically acceptable salt, solvate, hydrate, and/or N-oxide thereof, one or more known pharmaceutical agents selected from analgesic agents and antidiabetic agents, and a pharmaceutically acceptable carrier.
A · US 2014/0206649 A1 · ¶ 21
A tremendous demand therefore exists for new methods and compositions that can be used to treat patients with cancer.
B · US 2015/0005303 A1 · ¶ 4
Accordingly, compounds that can control angiogenesis or inhibit the production of certain cytokines, including TNFα, may be useful in the treatment and prevention of various diseases and conditions.
B · US 2015/0005303 A1 · ¶ 7
Cite aspatent.fyi, US 2026/0356819 A1, claim 1, first published 2026-11-20T07:31:16-05:00, https://patent.fyi/US20260356819/, SHA-256 fe6564173e64747333e9f6e0a3788255fec0ace1357ab54f54c0c2b48d7c9c48
First published
Permanent addresshttps://patent.fyi/US20260356819/
Content fingerprint (SHA-256)fe6564173e64747333e9f6e0a3788255fec0ace1357ab54f54c0c2b48d7c9c48
Methodv2026-11-18.2 · automated, not reviewed by a person
Correctionscorrections@patent.fyi